814
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Study protocol for the targeting effective analgesia in clinics for HIV (TEACH) study – a cluster randomized controlled trial and parallel cohort to increase guideline concordant care for long-term opioid therapy among people living with HIV

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon, , , ORCID Icon, , & ORCID Icon show all
Pages 48-63 | Received 02 Jan 2019, Accepted 30 May 2019, Published online: 08 Jul 2019

References

  • Volkow N, Benveniste H, McLellan AT. Use and misuse of opioids in chronic pain. Annu Rev Med. 2018;69:451–465.
  • Williams AR, Bisaga A. From AIDS to opioids — how to combat an epidemic. N Engl J Med. 2016;375(9):813–815. http://dx.doi.org/10.1056/NEJMp1604223.
  • Stitzer ML, Schwartz RP, Bigelow GE. Prescription opioids: new perspectives and research on their role in chronic pain management and addiction. Drug Alcohol Depend. 2017;173 Suppl 1:S1–S3. doi:S0376-8716(16)31025-0.
  • Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374:154–163.
  • Substance Abuse and Mental Health Services Administration. Drug abuse warning network, 2011: National estimates of drug-related emergency department visits. 2013;(SMA) 13-4760, DAWN Series D-39.
  • Martins SS, Sarvet A, Santaella-Tenorio J, Saha T, Grant BF, Hasin DS. Changes in us lifetime heroin use and heroin use disorder: prevalence from the 2001-2002 to 2012-2013 national epidemiologic survey on alcohol and related conditions. JAMA Psychiatry. 2017;74:445–455.
  • Centers for Disease Control and Prevention (CDC). CDC guideline for prescribing opioids for chronic pain — united states, 2016 . https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm. Updated 2016. Accessed January 2, 2018.
  • Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–130.e22.
  • Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons receiving medical care for HIV infection medical monitoring project, United States 2013 cycle. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-hssr-mmp-2013.pdf. Updated January 2016. Accessed December 19, 2018, HIV Surveillance Special Report 16.
  • Jiao JM, So E, Jebakumar J, George MC, Simpson DM, Robinson-Papp J. Chronic pain disorders in HIV primary care: clinical characteristics and association with healthcare utilization. J Int Assoc Study Pain. 2016;157(4):931–937.
  • Parker R, Stein DJ, Jelsma J. Pain in people living with HIV/AIDS: a systematic review. JIAS. 2014;17:18719.
  • Merlin J, Westfall A, Chamot E, et al. The relationship of pain to physical function in patients with HIV: an underappreciated phenomenon. Pain. 2012;45(2):404–405.
  • Miaskowski C, Penko JM, Guzman D, Mattson JE, Bangsberg DR, Kushel MB. Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. J Pain. 2011;12(9):1004.
  • Merlin JS, Cen L, Praestgaard A, et al. Pain and physical and psychological symptoms in ambulatory HIV patients in the current treatment era. J Pain Symp Manage. 2012;43(3):638.
  • Breitbart W, McDonald MV, Rosenfeld B, et al. Pain in ambulatory AIDS patients. I: pain characteristics and medical correlates. Pain. 1996;68:315.
  • Dobalian A, Tsao JC, Duncan RP. Pain and the use of outpatient services among persons with HIV: results from a nationally representative survey. Med Care. 2004;42(2):129–138.
  • Vogl D, Rosenfeld B, Breitbart W, et al. Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage. 1999;18(4):253.
  • Fantoni M, Ricci F, Del Borgo C, et al. Multicentre study on the prevalence of symptoms and symptomatic treatment in HIV infection. central Italy PRESINT group. J Palliat Care. 1997;13(2):9–13.
  • Larue F, Fontaine A, Colleau SM. Underestimation and undertreatment of pain in HIV disease: multicentre study. BMJ. 1997;314:23–28.
  • Namisango E, Harding R, Atuhaire L, et al. Pain among ambulatory HIV/AIDS patients: Multicenter study of prevalence, intensity, associated factors, and effect. J Pain. 2012;13(7):704.
  • Richardson J, Barkan S, Cohen M, et al. Experience and covariates of depressive symptoms among a cohort of HIV infected women. Soc Work Health Care. 2001;32(4):93–111.
  • Lee KA, Gay C, Portilla CJ, et al. Symptom experience in HIV-infected adults: a function of demographic and clinical characteristics. J Pain Symp Manage. 2009;38(6):882–892.
  • Del Borgo C, Izzi I, Chiarotti F, et al. Multidimensional aspects of pain in HIV-infected individuals. AIDS Patient Care STDS. 2001;15(2):95.
  • Frich LM, Borgbjerg FM. Pain and pain treatment in AIDS patients: a longitudinal study. J Pain Symp Manage. 2000;19(5):339–347.
  • Merlin JS, Zinski A, Norton WE, et al. A conceptual framework for understanding chronic pain in patients with HIV. Pain Pract. 2013;14(3):207–216.
  • Silverberg MJ, Ray GT, Saunders K, et al. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012;28(1):39–46.
  • Edelman EJ, Gordon K, Becker WC, et al. Receipt of opioid analgesics by HIV-infected and uninfected patients. J Gen Intern Med. 2013;28(1):82–90.
  • Merlin JS, Tamhane A, Starrels JL, Kertesz S, Saag M, Cropsey K. Factors associated with prescription of opioids and co-prescription of sedating medications in individuals with HIV. AIDS Behav. 2016;20(3):687–698.
  • Becker WC, Gordon K, Jennifer Edelman E, et al. Trends in any and high-dose opioid analgesic receipt among aging patients with and without HIV. AIDS Behav. 2016;20(3):679–686.
  • Gaither JR, Goulet JL, Becker WC, et al. Guideline-concordant management of opioid therapy among human immunodeficiency virus (HIV)-infected and uninfected veterans. J Pain. 2014;15(11):1130–1140.
  • Turner AN, Maierhofer CT, Funderburg NT, et al. High levels of self-reported prescription opioid use by HIV-positive individuals. AIDS Care. 2016;28:1559–1565.
  • Park TW, Nelson K, Xuan Z, Lasser KE, Liebschutz JM, Saitz R. The association between benzodiazepine prescription and aberrant drug behaviors in primary care patients receiving chronic opioid therapy. Drug Alcohol Depend. 2015;146:e61–e62.
  • Vijayaraghavan M, Penko J, Bangsberg DR, Miaskowski C, Kushel MB. Opioid analgesic misuse in a community-based cohort of HIV-infected indigent adults. JAMA Internal Med. 2013;173(3):235–237.
  • Hansen L, Penko J, Guzman D, Bangsberg DR, Miaskowski C, Kushel MB. Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals. J Pain Symp Manage. 2011;42(6):893–902.
  • Robinson-Papp J, Elliott K, Simpson DM, Morgello S, Manhattan HIV Brain Bank. Problematic prescription opioid use in an HIV-infected cohort: the importance of universal toxicology testing. J Acquir Immune Defic Syndr. 2012;61(2):187–193.
  • Passik SD, Kirsh KL, Donaghy KB, Portenoy RK. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain. 2006;22:173–181.
  • Barry DT, Goulet JL, Kerns RK, et al. Nonmedical use of prescription opioids and pain in veterans with and without HIV. Pain. 2011;152(5):1133–1138.
  • Colasanti J, Lira MC, Cheng DM, et al. Chronic opioid therapy in HIV-infected patients: patients’ perspectives on risks, monitoring and guidelines. Clin Infect Dis. 2019;68:291–297
  • Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain. 2007;130(1–2):144–156.
  • Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiat. 2001;58(8):721–728.
  • Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–387.
  • Tsui JI, Cheng DM, Coleman SM, et al. Pain is associated with heroin use over time in HIV-infected Russian drinkers. Addiction. 2013;108(10):1779–1787.
  • Merlin JS, Westfall AO, Raper JL, et al. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, ART adherence, and virologic failure. J Acquir Immune Defic Syndr. 2012;61:154–170.
  • Tsao JC, Dobalian A, Stein JA. Illness burden mediates the relationship between pain and illicit drug use in persons living with HIV. Pain. 2005;119(1–3):124–132.
  • Tsao JC, Stein JA, Ostrow D, Stal RD, Plankey MW. The mediating role of pain in substance use and depressive symptoms among multicenter AIDS cohort study (MACS) participants. Pain. 2011;08:24.
  • Morasco BJ, Gritzner S, Lewis L, Oldham R, Turk DC, Dobscha SK. Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain. 2011;152(3):488–497.
  • Brennan PL, Schutte KK, Moos RH. Pain and use of alcohol to manage pain: prevalence and 3-year outcomes among older problem and non-problem drinkers. Addiction. 2005;100(6):186–777.
  • Holahan CJ, Moos RH, Holahan CK, Cronkite RC, Randall PK. Drinking to cope, emotional distress and alcohol use and abuse: a ten-year model. J Stud Alcohol. 2001;62(2):190–198.
  • Merlin JS, Long D, Becker WC, et al. The association of chronic pain and long-term opioid therapy with HIV treatment outcomes. J Acquir Immune Defic Syndr. 2018:79:77–82.
  • Becker WC, Fiellin DA, Gallagher RM, Barth KS, Ross JT, Oslin DW. The association between chronic pain and prescription drug abuse in veterans. Pain Med. 2009;10(3):531–536.
  • Novak SP, Herman-Stahl M, Flannery B, Zimmerman M. Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the united states. Drug Alcohol Depend. 2009;100(1–2):63–70.
  • Bruce RD, Merlin J, Lum PJ, et al. 2017 HIVMA of IDSA clinical practice guideline for the management of chronic pain in patients living with HIV. Clin Infect Dis. 2017;65:e1–e37.
  • Carroll JJ, Colasanti J, Lira MC, del Rio C, Samet JH. HIV physicians and chronic opioid therapy: it’s time to raise the bar. AIDS Behav. 2019;23:1057–1061.
  • Vijayaraghavan M, Penko J, Guzman D, Miaskowski C, Kushel MB. Primary care providers' views on chronic pain management among high-risk patients in safety net settings. Pain Med. 2012;13:1141–1148.
  • Lum PJ, Little S, Botsko M, et al. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings. J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S91–S97.
  • Anderson D, Zlateva I, Khatri K, Ciaburri N. Using health information technology to improve adherence to opioid prescribing guidelines in primary care. Clin J Pain. 2015;31(6):573–579.
  • Wang J, Christo PJ. The influence of prescription monitoring programs on chronic pain management. Pain Physician. 2009;12(3):507–515.
  • Ceasar R, Chang J, Zamora K, et al. Primary care providers’ experiences with urine toxicology tests to manage prescription opioid misuse and substance use among chronic noncancer pain patients in safety net health care settings. Subst Abuse. 2016;37(1):154–160.
  • Jacobs SC, Son EK, Tat C, Chiao P, Dulay M, Ludwig A. Implementing an opioid risk assessment telephone clinic: outcomes from a pharmacist-led initiative in a large veterans health administration primary care clinic, December 15, 2014–March 31, 2015. Subst Abuse. 2016;37(1):15–19.
  • Jamison RN, Ross EL, Michna E, Chen LQ, Holcomb C, Wasan AD. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial. Pain. 2010;150(3):390–400.
  • Lange A, Lasser KE, Xuan Z, et al. Variability in opioid prescription monitoring and evidence of aberrant medication taking behaviors in urban safety-net clinics. Pain. 2015;156(2):335–340.
  • Wakeland W, Nielsen A, Schmidt TD, et al. Modeling the impact of simulated educational interventions on the use and abuse of pharmaceutical opioids in the united states: a report on initial efforts. Health Educ Behav. 2013;40(1 Suppl):74S–86S.
  • Wiedmer NL, Harden PS, Isabelle PD, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med. 2007;8(7):573–584.
  • Wagner EH, Austin BT, Von Korff M. Improving outcomes in chronic illness. Manage Care Q. 1996;4(2):12–25.
  • Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288(14):1775–1779.
  • Ducharme LJ, Chandler RK, Harris AHS. Implementing effective substance abuse treatments in general medical settings: mapping the research terrain. J Subst Abuse Treat. 2016;60:110–118.
  • Merlin JS, Bulls HW, Vucovich LA, Edelman EJ, Starrels JL. Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review. AIDS Care. 2016;28:1506–1515.
  • Lasser KE, Shanahan C, Parker V, et al. A multicomponent intervention to improve primary care provider adherence to chronic opioid therapy guidelines and reduce opioid misuse: a cluster randomized controlled trial protocol. J Subst Abuse Treat. 2016;60:101–106.
  • Liebschutz JM, Xuan Z, Shanahan CW, et al. Improving adherence to long-term opioid therapy guidelines to reduce opioid misuse in primary care: a cluster-randomized clinical trial. JAMA Int Med. 2017;177(9):1265–1272.
  • Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.
  • Fox AD, Kunis HV, Starrels JL. Which skills are associated with residents' sense of preparedness to manage chronic pain? J Opioid Manage. 2012;8(5):328–336.
  • Weiss L, Egan JE, Botsko M, Netherland J, Fiellin DA, Finkelstein R. The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment. J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S7—S13.
  • Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
  • LaBelle CT, Choongheon Han S, Bergeron A, Samet JH. Office-based opioid treatment with buprenorphine (OBOT-B): Statewide implementation of the Massachusetts collaborative care model in community health centers. JSAT. 2016;60:6–13.
  • Joseph AM, Fu SS, Lindgren B, et al. Chronic disease management for tobacco dependence: a randomized, controlled trial. Arch Intern Med. 2011;171(21):1894–1900.
  • Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611–2620.
  • Piatt GA, Orchard TJ, Emerson S, et al. Translating the chronic care model into the community: results from a randomized controlled trial of a multifaceted diabetes care intervention. Diabetes Care. 2006;29(4):811–817.
  • Alford DP, Labelle CT, Kretsch N, et al. Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience. Arch Intern Med. 2011;171(5):425–431.
  • Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med. 2005;6(6):432–442.
  • Larance B, Bruno R, Lintzeris N, et al. Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: the opioid-related behaviours in treatment (ORBIT) scale. Drug Alcohol Depend. 2016;159:42–52.
  • Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57(12):1288–1294.
  • National Institute on Drug Abuse: Seek, Test, Treat and Retain Initiative. HIV/HCV/STI testing status and organizational testing practices questionnaire. http://www.drugabuse.gov/researchers/research-resources/data-harmonization-projects/seek-test-treat-retain/addressing-hiv-among-vulnerable-populations. Updated 2013.
  • Cleeland CS. Brief pain inventory: short form. 1991.
  • Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289(18):2370–2378.
  • Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004;20(5):309–318.
  • Gunnarsdottir S, Donovan HS, Serlin RC, Voge C, Ward S. Patient-related barriers to pain management: the barriers questionnaire II (BQ-II). Pain. 2002;99(3):385–396.
  • Zallman L, Rubens SL, Saitz R, Samet JS, Lloyd-Travaglini C, Liebschutz J. Attitudinal barriers to analgesic use among patients with substance use disorders. Pain Res Treat. 2012;2012:1–7.
  • Anderson LA, Dedrick RF. Development of the trust in physician scale: a measure to assess interpersonal trust in patient-physician relationships. Psychol Rep. 1990;67(3 Pt 2):1091–1100.
  • Thom DH, Ribisl KM, Stewart AL, Luke DA. Further validation and reliability testing of the trust in physician scale. The Stanford trust study physicians. Med Care. 1999;37(5):510–517.
  • Hall MA, Zheng B, Dugan E, et al. Measuring patients' trust in their primary care providers. Med Care Res Rev. 2002;59(3):293–318.
  • Meltzer EC, Rybin D, Saitz R, et al. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the current opioid misuse measure (COMM). Pain. 2011;152(2):397–402.
  • Ashrafioun L, Bohnert AS, Jannausch M, Ilgen MA. Evaluation of the current opioid misuse measure among substance use disorder treatment patients. J Subst Abuse Treat. 2015;55:15–20.
  • Larance B, Campbell G, Peacock A, et al. Pain, alcohol use disorders and risky patterns of drinking among people with chronic non-cancer pain receiving long-term opioid therapy. Drug Alcohol Dependence. 2016;162:79–87.
  • McLellan AT, Luborsky L, O'Brien C, Woody GE. An improved diagnostic instrument for substance abuse patients, the addition severity index. J Nervous Mental Dis. 1980;168:26–33.
  • Institute of Behavioral Research. TCU drug screen V. 2014.
  • Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT the Alcohol use Disorders Identification Test: Guidelines for Use in Primary Care. 2nd ed. World Health Organization; Geneva, Switzerland, 2001:41.
  • Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med. 2005;352(6):596–607.
  • HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group. THe HIV/AIDS treatment adherence, health outcomes and cost study: conceptual foundations and overview. AIDS Care. 2004;S1:S6–S21.
  • Tilton SR. Review of the state-trait anxiety inventory (STAI). News Notes. 2008;48(2):1–3.
  • Spielberger CD, Gorsuch RL, Lushene R, Vagg P, Jacobs G. Manual for the state-trait anxiety scale. Consulting Psychologists. 1983.
  • Herge WM, Landoll RR, La Greca RE, Allen NB. Cneter for epidemiological studies depression scales (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging. 2013:12;366–367.
  • Lewinsohn PM, Seeley JR, Roberts RE, Allen NB. Center for epidemiologic studies depression scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging. 1997;12(2):277.
  • Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD checklist for DSM-5 (PCL-5). National Center for PTSD. 2010.
  • Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36(8):588–594.
  • Selim AJ, Rogers W, Fleishman JA, et al. Updated U.S. population standard for the veterans RAND 12-item health survey (VR-12). Qual Life Res. 2009;18(1):43–52.
  • Berry SH. HCSUS baseline questionnaire. http://www.rand.org/health/projects/hcsus/Base.html. Updated 2002.
  • Fleishman JA, Sherbourne CD, Crystal S, et al. Coping, conflictual social interactions, social support, and mood among HIV-infected person. Am J Commun Psychol. 2000;28(4):421–453.
  • Hays RD, Cunningham WE, Ettl MK, Beck CK, Shapiro MF. Health related quality of life in HIV disease. Assessments. 1995;2(4):363–380.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.